Who Owns Anbio Biotechnology Stock?
NASDAQ: NNNNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 5.01%
- Held by insiders
- 4.79%
- Institutional holders
- 14
- Institutions 5.0%
- Insiders 4.8%
- Public and other 90.2%
Who owns Anbio Biotechnology stock?
Institutional investors own about 5.0% of Anbio Biotechnology's shares, spread across 14 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 4.79% of NNNN.
The largest institutional holders are Geode Capital Management, LLC (0.06%), Bank of America Corporation (0.03%) and BNP Paribas Financial Markets (0.03%). Together, the top 10 institutions control 0.2% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their NNNN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NNNN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 26.74K | 0.06% | +3.8% |
| Bank of America Corporation | 13.42K | 0.03% | +100.0% |
| BNP Paribas Financial Markets | 11.80K | 0.03% | +13.5% |
| Marshall Wace LLP | 11.50K | 0.03% | +100.0% |
| Morgan Stanley | 7.23K | 0.02% | -1.5% |
| UBS Group AG | 828 | 0.00% | -86.9% |
| Eversource Wealth Advisors, Llc | 187 | 0.00% | -29.7% |
| Osaic Holdings Inc. | 77 | 0.00% | +100.0% |
| JPMORGAN CHASE & CO | 53 | 0.00% | +100.0% |
| Bare Financial Services, Inc | 15 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NNNN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 26.74K | 0.06% |
| Northern Funds-SMALL CAP CORE FUND | 7.14K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Anbio Biotechnology?
Geode Capital Management, LLC is the largest institutional shareholder of NNNN, owning 0.06% of shares outstanding (26.74K shares) as of its latest 13F filing.
What percentage of Anbio Biotechnology is owned by institutions?
Institutions own about 5.0% of NNNN shares and 5.3% of the public float.
How much of Anbio Biotechnology do insiders own?
Insiders, such as officers and directors, own about 4.79% of NNNN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.